EZH2 and breast cancer: These results are in full agreement with recent reports of H1.2 prevalence in repressed genes in breast cancer cells and oncogenic role for EZH213, 46, 47, and offer a mechanistic explanation for the requirement of H1.2 during EZH2-mediated cancer development.